Arkolith/Insider Trading/ANIK/Form 4

Nunes Anne

SVP, Chief Operations OfficerAnika Therapeutics, Inc. (ANIK) · full profile →Form 4 · filed Mar 18, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2025Tax withholding(F)1K$15.91$17K21K
Mar 17, 2025Option exercise(M)4K—$022K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 17, 2025Option exercise(M)4K—$07K
Mar 14, 2025Grant(A)21K—$021K
Mar 14, 2025Grant(A)5K—$05K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-25-001534) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML